Safety & Efficacy of BRAF Inhibitor Plixorafenib in Children & Adults with Recurrent, BRAF altered PCNSTs

October 17, 2024 9:37 AM EDT

Read More

Press Release Oct 08 2024 FORE Biotherapeutics Presents at RBC Capital Markets 2024 Virtual Biotechnology Private Company Conference Read more

Press Release Sep 26 2024 FORE Biotherapeutics Presents at UBS 2024 Biotechnology Private Company Virtual Symposium Read more

Press Release Sep 04 2024 FORE Biotherapeutics to Participate in Upcoming Investor Conferences Read more